Disruptive, patented microfluidic extraction and hybridization technology
Quantitative analysis of rationally derived candidate biomarker panels
Service platform to identify both taxonomic and functional novel candidate biomarkers from the gut microbiome
Enabling rapid, low cost accurate analysis for for microbiome-based precision medicine